SUTRO BIOPHARMA, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sutro Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
  • Sutro Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$48M, a 24.6% decline year-over-year.
  • Sutro Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$124M, a 12.8% increase year-over-year.
  • Sutro Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$107M, a 10.4% increase from 2022.
  • Sutro Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$119M, a 12.9% decline from 2021.
  • Sutro Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$106M, a 228% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$107M +$12.4M +10.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$119M -$13.7M -12.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$106M -$73.4M -228% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-25
2020 -$32.1M +$87.1M +73% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 -$119M -$83.9M -238% Jan 1, 2019 Dec 31, 2019 10-K 2023-03-30
2018 -$35.3M -$15.6M -79.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 -$19.7M -$21.4M -1257% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $1.7M Jan 1, 2016 Dec 31, 2016 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.